Application of mechanistic preclinical PK/PD/efficacy modeling to support combination strategy for AZD9750, a novel oral androgen receptor degrader (PROTAC)
Ana Quiroga; Pablo Morentin Gutierrez; Antonio Ramos-Montoya; Chrysiis Michaloglou; Nuria Galeano-Dalmau; Claire Crafter; Aaron Smith; Jamie Scott; Michael Niedbala
Portal del Investigador